MJ

Mahesh Jaylal Dadhia

Active Director Director DIN 01804748
DIN 01804748 First appointment Mar 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Mar 2007
Shareholding value •••• Premium profile

About Mahesh Jaylal Dadhia

Data last updated:

Mahesh Jaylal Dadhia is a Director at Synthiko Formulations & Pharma Private Limited (since 2007). The companies operate in Pharma. Synthiko Formulations & Pharma Private Limited reported revenue of ₹2.13 Cr (FY 2020). Earlier, Mahesh Jaylal Dadhia was a Director at Transbiotic Pharma Private Limited (from 2010).

DIN 01804748
Primary Designation Director
Industry Pharma
First Appointment 12 Mar 2007
Oldest Company Age 19 yrs
Largest company Synthiko Formulations & Pharma Private Limited · ₹2.13 Cr (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Mar 20072007₹2.13 Cr (FY 2020)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Transbiotic Pharma Private Limited U33110MH2010PTC209812
Director03 Nov 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Mahesh Jaylal Dadhia

NameDINCompanyDesignation
Poonam Gupta08243836Synthiko Formulations & Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Transbiotic Pharma Private Limited
Synthiko Formulations & Pharma Private Limited
Premium access

Shareholding and investment profile for Mahesh Jaylal Dadhia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Jaylal Dadhia

Mahesh Jaylal Dadhia currently holds 1 directorship: Synthiko Formulations & Pharma Private Limited (Director, since 12 Mar 2007, revenue ₹2.13 Cr (FY 2020)).

Mahesh Jaylal Dadhia was first appointed on 12 Mar 2007 as Director at Synthiko Formulations & Pharma Private Limited. The most recent appointment on record is 03 Nov 2010 at Transbiotic Pharma Private Limited.

Mahesh Jaylal Dadhia held 1 earlier board appointment: Transbiotic Pharma Private Limited (Director, from 03 Nov 2010).

The current boards of Mahesh Jaylal Dadhia's companies include Poonam Gupta (Synthiko Formulations & Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available